European Healthtech startup funding raised during March 2016.
In March 2016, 23 European Healthtech companies raised a combined €87M across 23 funding rounds, up 10.1% versus March 2015. UK led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 23 Aug 2026.
2 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Cambridge Epigenetix | Series B | Mar 2016 | €19M |
| Rythm | Series A | Mar 2016 | €10M |
| Bluebee | Series A | Mar 2016 | €10M |
| Medasense Biometrics | Series B |
| Mar 2016 |
| €7.3M |
| Kiweno | Early VC | Mar 2016 | €7.0M |
| FineHeart | Series A | Mar 2016 | €6.4M |
| Simris Alg | Seed | Mar 2016 | €5.5M |
| Coala Life | Seed | Mar 2016 | €3.2M |
| Amal Therapeutics | Series A | Mar 2016 | €2.8M |
| KeyNatura | Seed | Mar 2016 | €2.2M |
| Finox Biotech | Early VC | Mar 2016 | €2.1M |
| Brainshake | Seed | Mar 2016 | €2.0M |
| Neteera | Series A | Mar 2016 | €1.8M |
| MedyMatch | Seed | Mar 2016 | €1.8M |
| DiACardio | Seed | Mar 2016 | €1.8M |